Photocure | Sustainability Performance
Photocure is engaged in pharmaceutical development, with a focus on products for the treatment of bladder cancer. The company aims to advance patient care through innovative therapies while emphasizing safety and efficacy in its product offerings.
1993
Norway
51 - 200 employees
Pharmaceuticals
$25M - 100M in revenue
$0 - 100K in profitability
Submit or report inaccurate dataDownload Company InsightsⓘBy downloading this report, you'll receive the most insightful and detailed analysis of the company's sustainability performance, compared to its peers. It includes key industry trends, carbon and energy intensity, nature impact, social metrics, and an in-depth look at key risks and controversies.
Sustainability Ranking & Industry Benchmark
#7384
Overallⓘ#160
in Norwayⓘ#172
in PharmaceuticalsⓘSustainability Maturity
ⓘSustainability Intent
ⓘOverview
Controversy level
- Photocure's marketing of Hexvix for bladder cancer detection was scrutinized for claims about diagnostic accuracy improvements.
Sustainability employees
ⓘWe follow the strictest rules to ensure compliance with all the relevant data protection laws, including GDPR. Click here for our Privacy Policy.Total sustainability employees
2-3
ⓘThis value represents the estimated number of employees in a company with sustainability-related roles or job titles, as determined by Illuminem using publicly available data.